pharmaceuticals

Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of the best entry points in months. The stocks also are rated Buy at top...
With the potential for far lower returns in the coming year, total return becomes a key ingredient for investment success. These five top health care stocks look like very solid ideas for 2022, as...
Current shortages in the goods people normally buy extend to these 100+ medications.
In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer strong balance sheets, attractive dividend yields and improved cost...
Most of the most prescribed medications in America are to treat pain or lower the risk of heart disease. At the top of that list, according to Medicine.net, are Vicodin, Zocor and Metformin. Many of...
These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for investors, especially now that the market is overbought and the slow seasonal market...
Johnson & Johnson officially enters the fight against COVID-19 as its single-shot vaccine was approved over the weekend. It plans to deliver 100 million single-shot vaccines during the first half of...
Rome was not built in a day, and neither are multibillion-dollar corporations. Biopharmaceuticals company AbbVie is the largest American company founded in the past decade.
In addition to rising hopes for a change in U.S. law removing marijuana from a list of dangerous drugs, a swarm of retail investors has been taking aim at pot stock short sellers. Here's how that's...
London-based Jazz Pharmaceuticals has agreed to pay $7.2 billion to acquire GW Pharmaceuticals, a maker of drugs derived from cannabis plants.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...